A common way to manage coronary heart disease is coming under question. To prevent a repeat heart attack or stroke, many patients of a certain age are currently advised to take low-dose aspirin each day, indefinitely.

Emerging evidence suggests a better option already exists.

A recent meta-analysis by an international team of cardiologists finds that clopidogrel – which stops blood platelets from clumping – is a superior choice to aspirin in the long run for patients with established coronary artery disease.

The oral drug works among various age groups, ethnicities, sexes, and body sizes, and it's highly effective at 'thinning' the blood.

Compared to aspirin, clopidogrel lowers the risk of a future heart attack, stroke, or cardiovascular death by roughly 14 percent, and important

See Full Page